Seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey.

Seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey.

Item
http://www.wikidata.org/entity/Q44781282
Assessment of Obesity and Hepatic Late Adverse Effects in the Egyptian Survivors of Pediatric Acute Lymphoblastic Leukemia: a Single Center Study.Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.Chronic hepatitis B in children with or without malignancies: a 13-year follow-upAssessment of hepatitis B immunization status after antineoplastic therapy in children with cancer.Seroprevalence of hepatitis B and C among oncology patients in TurkeyNatural history and response to treatment of HCV infection among Egyptian survivors of childhood malignancy.Prevalence of hepatitis C infection among children with β-thalassaemia major in Mid Delta, Egypt: a single centre study.A national mapping assessment of blood collection and transfusion service facilities in Afghanistan.Hepatitis B Virus Seroprevalence Among Children With Cancer in Sudan.Occult hepatitis B virus infection as a cause of posttransfusion hepatitis in patients with cancers.
P2860

Seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey.

Item
http://www.wikidata.org/entity/Q44781282
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Seroprevalence of hepatitis B, ...... d following therapy in Turkey.
@en
Seroprevalence of hepatitis B, ...... d following therapy in Turkey.
@nl
type
label
Seroprevalence of hepatitis B, ...... d following therapy in Turkey.
@en
Seroprevalence of hepatitis B, ...... d following therapy in Turkey.
@nl
prefLabel
Seroprevalence of hepatitis B, ...... d following therapy in Turkey.
@en
Seroprevalence of hepatitis B, ...... d following therapy in Turkey.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Seroprevalence of hepatitis B, ...... d following therapy in Turkey.
@en
P2093
P2860
P304
P31
P356
10.1002/(SICI)1096-911X(200002)34:2<102::AID-MPO5>3.0.CO;2-#
P433
P478
P577
P698
P921